UNITED ~~STATES~~STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549

~~SECURITIES AND EXCHANGE COMMISSION~~_______________

Washington, D.C. 20549

FORM 6-K

~~REPORT OF FOREIGN PRIVATE ISSUER~~_______________

~~PURSUANT~~REPORT OF FOREIGN PRIVATE ISSUERPURSUANT TO RULE 13a-16 OR 15d-1616UNDER THE SECURITIES EXCHANGE ACT OF 1934

~~UNDER~~For ~~THE~~the ~~SECURITIES~~month ~~EXCHANGE~~of ~~ACT OF 1934~~November 2025

~~For the month of October 2025~~_______________

~~Commission~~Park ~~File~~Ha ~~Number:~~Biological ~~001-42453~~Technology Co., Ltd.(Exact name of registrant as specified in its charter)

~~Park Ha Biological Technology Co., Ltd.~~_______________

901, Building CCPhase 2, ~~Phase~~Wuxi International Life Science Innovation Campus196 Jinghui East RoadXinwu District, 2Wuxi, Jiangsu ProvincePeople’s Republic of China 214000(Address of Principal Executive Office)

~~Wuxi International Life Science Innovation Campus~~_______________

~~196~~Indicate ~~Jinghui~~by ~~East~~check ~~Road~~mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Xinwu District, Wuxi, Jiangsu Province

People’s Republic of China 214000

+86 400 012 7562

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

~~Change~~2025 ofExtraordinary ~~Trading~~General ~~Symbol~~Meeting

OnIn ~~October~~connection ~~24,~~with the 2025, extraordinary general meeting of Park Ha Biological Technology Co., Ltd., ~~(the “Company”) announced~~ a ~~change~~Cayman ofIslands ~~trading~~company ~~symbol for its ordinary shares to “BYAH”~~ (~~from~~the “~~PHH~~Company”), ~~which~~ the Company ~~anticipates~~hereby ~~will~~furnishes ~~become effective on~~ the ~~Nasdaq~~following ~~Stock Market at the open of trading on Monday October 28, 2025.~~documents:

~~On October 24, 2025, the Company issued a press release, a copy of which is attached hereto as Exhibit 99.1 to this Report of Foreign Private Issuer on Form 6-K, announcing the ticker symbol change.~~Exhibits

EXHIBIT INDEX

Exhibit No.		Description
99.1		Notice of 2025 Extraordinary General Meeting, dated November 28, 2025, to be mailed to the shareholders of the Company
99.2		Form of Proxy Card to be mailed to the shareholders of the Company

~~SIGNATURES~~SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Park Ha Biological Technology Co., Ltd.
Date: October 24, 2025	By:	/s/ Xiaoqiu Zhang
	Name:	Xiaoqiu Zhang
	Title:	Chief Executive Officer, Chairperson of the Board of Directors

Dated: November 28, 2025

		Park Ha Biological Technology Co., Ltd.
		By:		/s/ ZHANG Xiaoqiu
		Name:		ZHANG Xiaoqiu
		Title:		Chief Executive Officer and Chairperson of the Board

Filing Compare · Park Ha Biological Technology Co., Ltd.